IAS / IPS

Civil Services

LAEX IAS Jr.

Jr. Foundation

Inter

+ IAS / CUET

Inter

+ CLAT / IPMAT

CLAT / IPMAT

Entrance Prep

Pre Schools

Early Learning

Schools

Academic Excellence

Colleges

Higher Education

On cough syrups, a long overdue prescription (Indian Express)

Paper: GS – I/II, Subject: Society and Social Justice, Topic: Social Sector – Health, Issue: Schedule K Removal for cough syrups.

Context:

Recently, the Centre removed cough syrups from Schedule K of the Drugs Rules, 1945. This means cough syrups can no longer be sold under relaxed conditions and will now require stricter prescription-based control. The decision follows repeated child deaths linked to contaminated cough syrups.

Cough Syrup - Background
(Schedule K Removal and Safer Cough Syrup Regulation)

Key Takeaways:

Explanation:

Why the Change Was Needed:

  • Several deaths in India and abroad showed serious gaps in cough syrup regulation.
  • Unsafe products reached consumers because quality testing, inspections and supply-chain monitoring were weak.
  • Children are highly vulnerable because even small amounts of toxic chemicals can cause severe harm.
  • The earlier relaxed system made accountability difficult across manufacturers, sellers and regulators.

What Has Changed Now:

  • Cough syrups can no longer be easily sold as over-the-counter medicines under the earlier exemption.
  • A doctor’s prescription will be required to buy syrup-based medicines.
  • This can reduce misuse, careless consumption and unsafe treatment of children.
  • It also increases responsibility on doctors, pharmacists, manufacturers and regulators.

Continuing Problems:

  • Prescription control alone cannot ensure safety if manufacturing quality remains weak.
  • India’s drug regulation involves both the Centre and States, often causing coordination gaps.
  • Inspection capacity is uneven, allowing poor-quality medicines to enter the market.
  • Rural areas may face difficulty due to limited access to doctors and licensed pharmacies.

Way Forward:

  • India needs stricter factory inspections, regular quality testing and strong punishment for contamination.
  • Adverse drug reactions and deaths must be reported quickly and transparently.
  • Rural healthcare, licensed pharmacies and public awareness must be strengthened.

Conclusion:

The new rule is a necessary step to protect public health, especially children. However, real safety needs better manufacturing checks, stronger Centre-State coordination and improved rural healthcare. India must move from reacting after tragedies to preventing them in advance.

Source: (The Indian Express)

La Excellence IAS Academy, the best IAS coaching in Hyderabad, known for delivering quality content and conceptual clarity for UPSC 2026 preparation.

FOLLOW US ON:

◉ YouTube : https://www.youtube.com/@CivilsPrepTeam

◉ Facebook: https://www.facebook.com/LaExcellenceIAS

◉ Instagram: https://www.instagram.com/laexcellenceiasacademy/

GET IN TOUCH:

Contact us at info@laex.in, https://laex.in/contact-us/

or Call us @ +91 9052 29 2929+91 9052 99 2929+91 9154 24 2140

OUR BRANCHES:
Head Office: H No: 1-10-225A, Beside AEVA Fertility Center, Ashok Nagar Extension, VV Giri Nagar, Ashok Nagar, Hyderabad, 500020

Madhapur: Flat no: 301, survey no 58-60, Guttala begumpet Madhapur metro pillar: 1524,  Rangareddy Hyderabad, Telangana 500081

Bangalore: Plot No: 99, 2nd floor, 80 Feet Road, Beside Poorvika Mobiles, Chandra Layout, Attiguppe, Near Vijaya Nagara, Bengaluru, 560040

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to Top